|
Grouped-level disorder
|
Count
|
Overall prevalence
|
95% CI*
|
Female prevalence %
|
Male prevalence %
|
P-value
|
|---|
|
Dental
|
378
|
19.2
|
17.5–21.0
|
21.2
|
17.3
|
0.028
|
|
Enteropathy
|
270
|
13.7
|
12.2–15.3
|
11.6
|
15.9
|
0.006
|
|
Skin
|
250
|
12.7
|
11.2–14.2
|
11.6
|
13.7
|
0.159
|
|
Aural
|
197
|
10.0
|
8.7–11.4
|
9.8
|
10.3
|
0.718
|
|
Obesity
|
164
|
8.3
|
7.1–9.6
|
10.2
|
6.4
|
0.002
|
|
Anal sac
|
128
|
6.5
|
5.4–7.7
|
6.0
|
7.0
|
0.367
|
|
Mass-associated
|
123
|
6.2
|
5.2–7.4
|
5.7
|
6.8
|
0.311
|
|
Ophthalmological
|
112
|
5.7
|
4.7–6.8
|
5.7
|
5.7
|
0.991
|
|
Cardiac
|
85
|
4.3
|
3.5–5.3
|
5.6
|
3.1
|
0.005
|
|
Neoplastic
|
83
|
4.2
|
3.3–5.2
|
3.9
|
4.6
|
0.438
|
|
Musculoskeletal
|
80
|
4.1
|
3.2–5.0
|
4.1
|
4.1
|
0.993
|
|
Parasitic
|
77
|
3.9
|
3.1–4.9
|
4.3
|
3.6
|
0.411
|
|
Claw/nail
|
75
|
3.8
|
3.0–4.7
|
3.0
|
4.5
|
0.075
|
|
Traumatic injury
|
70
|
3.5
|
2.8–4.5
|
3.0
|
4.2
|
0.147
|
|
Behavioural
|
65
|
3.3
|
2.6–4.2
|
3.0
|
3.7
|
0.382
|
- The P-value reflects prevalence comparison between females and males. P-values that are less than 0.05 are highlighted in bold. *CI confidence interval
